secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2026-06-11T13:02:10+00:00
Accession:  0001116463-26-000046
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure receives FDA clearance for Colli-Pee Dx urine collection kit for STI tests on Roche systems
--------------------------------------------------------------------------------

- FDA clearance covers Colli-Pee Dx kit for use with Roche cobas 5800/6800/8800 systems for CT, NG, TV, MG pathogens.
- Kit enables at-home self-collection of first-void urine for both male and female patients.
- Subsidiary DNA Genotek's product expands OraSure's at-home diagnostics portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000111646326000046/0001116463-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000111646326000046/osur-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001116463-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer